Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Global Pain Management Drugs Market
Chapter 4. Global Pain Management Drugs Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Drugs Provider
4.1.2. Research and Development
4.1.3. Distributor
4.1.4. End Users
4.2. Industry Outlook
4.2.1. Pain relief techniques
4.3. PEST Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017-2030
4.7.2. Pricing Analysis
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2020
4.8.3. Competitor Product Mapping
Chapter 5. Global Pain Management Drugs Market Analysis, By Drug Class
5.1. Key Insights
5.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
5.2.1. NSAIDs
5.2.2. Anesthetics
5.2.3. Anticonvulsants
5.2.4. Anti-migraine Agents
5.2.5. Antidepressants
5.2.6. Opioids
5.2.7. Nonnarcotic Analgesics
Chapter 6. Global Pain Management Drugs Market Analysis, By Indication
6.1. Key Insights
6.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
6.2.1. Arthritic Pain
6.2.2. Neuropathic Pain
6.2.3. Cancer Pain
6.2.4. Chronic Back Pain
6.2.5. Postoperative Pain
6.2.6. Migraine
6.2.7. Fibromyalgia
6.2.8. Bone fracture
6.2.9. Muscle sprain
6.2.10. Acute appendicitis
6.2.11. Others
Chapter 7. Global Pain Management Drugs Market Analysis, By Pain Type
7.1. Key Insights
7.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
7.2.1. Chronic pain
7.2.2. Acute pain
Chapter 8. Global Pain Management Drugs Market Analysis, By Drug Type
8.1. Key Insights
8.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
8.2.1. Generics
8.2.2. Branded
Chapter 9. Global Pain Management Drugs Market Analysis, By Distribution Channel
9.1. Key Insights
9.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
9.2.1. Hospitals
9.2.2. Pharmacy Retail Stores
9.2.3. Online
Chapter 10. Global Pain Management Drugs Market Analysis, By Region/ Country
10.1. Key Insights
10.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
10.2.1. North America
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.1.3. Mexico
10.2.2. Europe
10.2.2.1. Western Europe
10.2.2.1.1. The UK
10.2.2.1.2. Germany
10.2.2.1.3. France
10.2.2.1.4. Italy
10.2.2.1.5. Spain
10.2.2.1.6. Rest of Western Europe
10.2.2.2. Eastern Europe
10.2.2.2.1. Poland
10.2.2.2.2. Russia
10.2.2.2.3. Rest of Eastern Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. Australia & New Zealand
10.2.3.5. ASEAN
10.2.3.6. Rest of Asia Pacific
10.2.4. Middle East & Africa (MEA)
10.2.4.1. UAE
10.2.4.2. Saudi Arabia
10.2.4.3. South Africa
10.2.4.4. Rest of MEA
10.2.5. South America
10.2.5.1. Brazil
10.2.5.2. Argentina
10.2.5.3. Rest of South America
Chapter 11. North America Pain Management Drugs Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
11.2.1. By Drug Class
11.2.2. By Indication
11.2.3. By Pain Type
11.2.4. By Drug Type
11.2.5. By Distribution Channel
11.2.6. By Country
Chapter 12. Europe Pain Management Drugs Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
12.2.1. By Drug Class
12.2.2. By Indication
12.2.3. By Pain Type
12.2.4. By Drug Type
12.2.5. By Distribution Channel
12.2.6. By Country
Chapter 13. Asia Pacific Pain Management Drugs Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
13.2.1. By Drug Class
13.2.2. By Indication
13.2.3. By Pain Type
13.2.4. By Drug Type
13.2.5. By Distribution Channel
13.2.6. By Country
Chapter 14. Middle East & Africa Pain Management Drugs Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
14.2.1. By Drug Class
14.2.2. By Indication
14.2.3. By Pain Type
14.2.4. By Drug Type
14.2.5. By Distribution Channel
14.2.6. By Country
Chapter 15. South America Pain Management Drugs Market Analysis
15.1. Key Insights
15.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
15.2.1. By Drug Class
15.2.2. By Indication
15.2.3. By Pain Type
15.2.4. By Drug Type
15.2.5. By Distribution Channel
15.2.6. By Country
Chapter 16. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
16.1. Abbott Laboratories
16.2. Allergen Inc.
16.3. Bayer AG
16.4. Boehringer Ingelheim
16.5. Bristol-Myers Squibb
16.6. Eli Lilly & Company
16.7. Endo Health Solutions, Inc.,
16.8. GlaxoSmithKline Plc.
16.9. Johnson & Johnson
16.10. Merck & Co. Inc.
16.11. Novartis AG
16.12. Ono pharmaceutical Co., Ltd.
16.13. Pfizer, Inc.
16.14. Purdue Pharma L.P.
16.15. Sorrento Therapeutics
16.16. Valeant Pharmaceuticals International Inc.
16.17. Viatris Inc.
16.18. WEX Pharmaceuticals
16.19. Zynerba Pharmaceuticals.
16.20. Other Prominent Players